Efficacy and safety of pegylated full‐length recombinant factor VIII with extended half‐life for perioperative haemostasis in haemophilia A patients-Reference-Cited by-同舟云学术

Efficacy and safety of pegylated full‐length recombinant factor VIII with extended half‐life for perioperative haemostasis in haemophilia A patients

Author:

Brand B.¹,Gruppo R.²,Wynn T. T.³,Griskevicius L.⁴,Lopez Fernandez M. F.⁵,Chapman M.⁶,Dvorak T.⁷,Pavlova B. G.⁷,Abbuehl B. E.⁷

Affiliation:

1. Universitaetsspital Zuerich Zuerich Switzerland

2. Cincinnati Children's Hospital Medical Center Cincinnati OHUSA

3. College of Medicine University of Florida Gainesville FL USA

4. Vilnius University Hospital Santariskiu Klinikos Medical Faculty of Vilnius University Vilnius Lithuania

5. Complejo Hospitalario Universitario A Coruña A Coruña Spain

6. Baxalta US Inc. Cambridge MA USA

7. Baxalta Innovations GmbH Vienna Austria

Funder

Baxalta

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

Reference31 articles.

5. Haemophilia and cancer: a personal perspective;Franchini M;Blood Transfus,2013

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献